Search by property

This page provides a simple browsing interface for finding entities described by a property and a named value. Other available search interfaces include the page property search, and the ask query builder.

List of results

• Reference:FRA Bonnes pratiques - CONTRÔLE QUALITÉ À DISTANCE DES ESSAIS CLINIQUES (CNIL) 16-May-2024 -  + (-)
• Reference:GBR Making changes to a research study to manage the impact of COVID-19 12-Oct-2021 -  + (-)
• Reference:GBR Guidance Managing clinical trials during Coronavirus (COVID-19) 16-Nov-.2021 -  + (-)
• Reference:GBR Guidance Access to Electronic Health Records by Sponsor representatives in clinical trials 44447 -  + (-)
• Reference:IMDRF IMDRF – Guidelines - -  + (-)
• Reference:USA CTCAE - Common Terminology Criteria for Adverse Events v5.0 (2017) -  + (-)
• Reference:DEU Bundestag - Sachstand zur Aufbewahrung von Patientenakten in der ambulanten Praxis Fristen und Form 01-Mar-2021 -  + (-)
• Reference:GBR NHS: Records Management Code of Practice 07-Aug-2023 -  + (-)
• Reference:AUT Question - BASG 11-Feb-2025 -  + (-)
• Reference:ICH ICH E3 Guideline 1995 -  + (-)
• Reference:N.A. (STROBE)statement: guidelines for reporting observational studies Apr-2008 -  + (-)
• Reference:GBR HRA - Ending your project 28-Jan-2025 -  + (-)
• Reference:DEU Deutsches Ärzteblatt 45849 -  + (-)
• Reference:EU European Medicines Agency’s Data Protection: Notice For Microsoft (MS) Copilot 365 - EMA pilot phase ; EMA/216030/2025 45838 -  + (-)
• Reference:WHO WHO Good Practices for Clinical Trial Design and Implementation 04-May-2026 -  + (-)
• Reference:N.A. Minimum Criteria for ICH E6 (R3) GCP Investigator Site Personnel Training V3.0 -  + (-)
• Reference:N.A. Transcelerate GCP mutual recognition programm FAQ 21-May-2025 -  + (-)
• Reference:GBR MHRA GCP Inspection Dossier template V7.0 -  + (-)
• Reference:USA WARNING LETTER - Purolea Cosmetics Lab MARCS-CMS 722591 46114 -  + (-)
• Reference:DEU Richtlinie zur Bewertung der Qualifikation von Prüfern, Hauptprüfern, Leitern und ärztlichen Mitgliedern von Prüfungsteams durch Ethik-Kommissionen von Arbeitskreis Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland e. V. und  + (-)
• Reference:ICH ICH E2F Guideline 2010 1  + (1)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.1-001  + (1.1)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.1-002  + (1.1)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Clinical Research  + (1.1 - Clinical Research)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - NIS  + (1.1 - NIS)

• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.1 - Platform, basket and umbrella trials  + (1.1 - Platform, basket and umbrella trials)

• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.2  + (1.2)
• Reference:DEU Gemeinsame Empfehlungen - zur Anzeige von Anwendungsbeobachtungen und nichtinterventionellen Unbedenklichkeits-studien 15-Dec-2022 1.3  + (1.3)
• Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 1.3  + (1.3)
• Reference:WHO WHO - Guidance for best practices for clinical trials 2024 1.4  + (1.4)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 1.4  + (1.4)
• Reference:USA NCI GUIDELINES FOR INVESTIGATORS: ADVERSE EVENT REPORTING REQUIREMENTS FOR DCTD (CTEP AND CIP) INDs AND IDEs 30-Aug-2024 1.4  + (1.4)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.1  + (10.1)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.2  + (10.2)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.3  + (10.3)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 10.3  + (10.3)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 10.4  + (10.4)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.6  + (10.6)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.7  + (10.7)
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.7 (e)  + (10.7 (e))
• Reference:ISO ISO 14155 - Clinical investigation of medical devices for human subjects 2020 10.8  + (10.8)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 11  + (11)
• Reference:EU GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC v5 10-Feb-2022 11 d)  + (11 d))
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 11.2  + (11.2)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 13  + (13)
• Reference:EU Eudralex - volume 4 GMP Guidelines Annex 11 Jan-2011 14  + (14)
• Reference:WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 2  + (2)
• Reference:EU Recommendations of the expert group - Risk proportionate approaches in clinical trials 25-Apr-2017 2.  + (2.)
• Reference:ICH ICH E21 Concept paper 2023 2.  + (2.)
• Reference:GBR Clinical investigations of medical devices – compiling a submission to MHRA May 2021 2.-001  + (2.)
• Reference:FRA AEC DOC012 v03 Avis aux promoteurs d’investigations cliniques de DM (RIPH1) – Partie II 16-May-2025 2.-001  + (2.)